Sign In
Buy TDOC
$7.09
-0.450 (-5.97%)
At Close: Jun 03, 2026
Teladoc Health: Buy After COVID-19 Bubble Ends
03:10am, Monday, 28'th Feb 2022 Seeking Alpha
These Are the 2 Most Important Numbers in Teladoc''s Earnings Report
11:00am, Sunday, 27'th Feb 2022 The Motley Fool
They show progress toward key goals.
Why Teladoc May Be One of the Best Growth Stocks to Buy in March
01:00pm, Saturday, 26'th Feb 2022 The Motley Fool
The business is a lot safer than the stock''s movement suggests.
These 18 Words From Teladoc''s CEO May Eliminate 1 Big Risk
11:00am, Friday, 25'th Feb 2022 The Motley Fool
This risk has been a concern among investors.
3 Big Misconceptions About Teladoc Health
10:52am, Thursday, 24'th Feb 2022 The Motley Fool
Here''s the real scoop about the virtual care leader.
Teladoc: The Bottom Is Here For Speculative Buyers
03:33am, Thursday, 24'th Feb 2022 Seeking Alpha
Why Teladoc Health Stock Initially Surged on Wednesday
07:28pm, Wednesday, 23'rd Feb 2022 The Motley Fool
The telehealth provider reported robust financial results then got dragged lower by a falling market.
Teladoc Health, Inc. 2021 Q4 - Results - Earnings Call Presentation
05:34pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Teladoc Health Analysts Give Mixed Prognosis Following Q4 Earnings
05:25pm, Wednesday, 23'rd Feb 2022 Benzinga
Shares of Teladoc Health, Inc. (NYSE: TDOC ) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter. The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100. Stifel analyst David Grossman maintained a Hold rating and lowered the price target from $83 to $74. KeyBanc Capital Markets analyst Donald Hooker reiterated an Overweight rating and took down the price target from $180 to $100. Teladoc''s Valuation Is Attractive, Needham Says: Teladoc finished fiscal year 2021 on a strong note, with revenue and adjusted EBITDA all exceeding the preannounced range, Needham analyst McDonald said. The delay in the launch of multiple chronic care customers has made revenues and margin expansion more weighted toward the second-half, the analyst said. Teladoc management shrugged it off, saying customers are already contracted and the outlook for the year remains … Full story available on Benzinga.
Thinking about trading options or stock in TJX Companies, Cerner Corp, Apple, Teladoc Health, or Roku?
04:05pm, Wednesday, 23'rd Feb 2022 Benzinga
NEW YORK , Feb. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TJX, CERN, AAPL, TDOC, and ROKU. Full story available on Benzinga.com
Teladoc Stock Looks Ready to Blow Up After Q4 Earnings
04:00pm, Wednesday, 23'rd Feb 2022 The Motley Fool
The company showed again why it is here to stay and is the dominant leader in its segment.
Palo Alto Networks, Teladoc, Virgin Galactic stocks up after reporting earnings
03:58pm, Wednesday, 23'rd Feb 2022 Yahoo Finance
Yahoo Finance''s Ines Ferre joins the Live show to break down how stocks are moving in early trading.
Teladoc extends losses as Wall Street reacts to post-earnings slump
12:39pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Teladoc Health (TDOC) continues to trade lower in the pre-market on Wednesday, extending its after-hours losses following the telehealth providers Q4 2021 results on Tuesday
Teladoc Health Posts Smaller Than Expected Q4 Loss, Issues Soft Q1 FY22 Outlook
11:56am, Wednesday, 23'rd Feb 2022 Benzinga
Teladoc Health Inc (NYSE: TDOC ) posted a narrower than expected Q4 EPS loss of $(0.07) versus consensus of $(0.56), and lower than $(3.07) reported a year ago. Q4 EPS loss included stock-based compensation expense of $(0.39) per share, amortization of acquired intangibles of $(0.28), and a non-cash income tax benefit of $0.31. Adjusted Gross margin improved to 68.4% from 67.9% a year ago. Adjusted EBITDA increased 53% to $77.1 Full story available on Benzinga.com
